You noticed a spot that wasn't there before, or a mole that looks a little different, and your first move was to point your phone at it. Maybe an app gave you a percentage, or a tidy list of possibilities, and now you're wondering whether you can trust it. That instinct is reasonable, and the technology behind it is real, but it works best when you understand exactly what it is.
An "AI dermatologist" is software trained on huge libraries of skin images to help flag, sort, and assess skin concerns, including possible skin cancers. The honest answer to "can it replace a real dermatologist?" is no. Leading dermatology organizations frame AI as a helper for clinicians and patients, not a substitute. Here is what the evidence actually shows.
What is an AI dermatologist?
An AI dermatologist isn't a person or a licensed doctor. It's a type of artificial intelligence, usually a deep neural network, trained to recognize patterns in images of skin. You upload or capture a photo, and the model compares it against patterns it learned from thousands or millions of labeled images to estimate what a spot might be or how concerning it looks.
The proof-of-concept moment came in 2017, when a Stanford team (Esteva and colleagues) trained a deep convolutional neural network on 129,450 clinical images spanning more than 2,000 diseases. On certain biopsy-proven classification tasks, the model matched or outperformed the average of 21 board-certified dermatologists. That study launched the modern "AI dermatologist" idea, but it tested narrow, specific tasks under controlled conditions, not the full judgment of an in-person exam.
- A consumer skin app that screens photos and suggests next steps
- A clinical decision-support tool that helps doctors evaluate lesions
- An FDA-cleared medical device used in a doctor's office to assess a specific spot
How accurate is AI at detecting skin cancer?
This is the question most people are really asking, and the data is genuinely encouraging, with caveats. A 2024 meta-analysis in npj Digital Medicine pooled many studies and found AI algorithms reached about 87.0% sensitivity and 77.1% specificity for skin cancer, compared with clinicians' roughly 79.8% sensitivity and 73.6% specificity. Notably, the highest performance of all came from AI-assisted dermatologists using dermoscopy, the combination, not AI alone.
Sensitivity means how often the tool correctly catches real cancers; specificity means how often it correctly clears benign spots. Higher specificity can mean fewer unnecessary biopsies. But these numbers come largely from curated image sets, and that matters for what they mean in your bathroom mirror.
Is there an FDA-cleared AI skin cancer tool?
Yes. On January 17, 2024, the FDA authorized DermaSensor, the first AI-powered device cleared to help primary-care clinicians detect all three common skin cancers: melanoma, basal cell carcinoma, and squamous cell carcinoma. It uses light-scattering spectroscopy plus an AI algorithm to assess a specific lesion a clinician is already evaluating.
In its DERM-SUCCESS validation (1,579 lesions across 1,005 patients), DermaSensor showed 95.5% sensitivity across all skin cancers. In a study of 108 primary care physicians, it cut missed skin cancers roughly in half, from 18% to 9%. Importantly, this is a tool used by a clinician in a medical setting, not a consumer app that diagnoses you on your own.
Why AI can't replace your dermatologist yet
The American Academy of Dermatology deliberately calls this "augmented intelligence," not artificial intelligence. Its position statement, first issued in 2019 and revised in August 2023, states that AI should assist and enhance the physician-patient relationship, not replace it.
There are real limits. A persistent concern flagged by JAMA Dermatology in 2025 is selection bias: many impressive accuracy figures come from pre-filtered "suspected melanoma" image sets, so performance can look better in studies than in messy, real-world practice. The AAD also warns about algorithmic bias, because many models were trained mostly on lighter skin tones and may perform worse on darker skin. And a photo can't feel a lesion's texture, review your history, or biopsy anything, which is still how skin cancer is confirmed.
- Selection bias: study images are often pre-screened, inflating real-world accuracy
- Skin-tone bias: many datasets underrepresent darker skin
- No physical exam: AI can't palpate, take history, or order a biopsy
- A confirmed diagnosis still requires a clinician and, often, a biopsy
How to use an AI dermatologist tool wisely
Used well, an AI skin tool is a smart triage step, a way to decide how urgently to act and to keep an organized record over time. Used poorly, it becomes false reassurance that delays care. The goal is to let AI raise your awareness, then loop in a human.
Skin cancer is the most common cancer in the U.S. The AAD estimates 1 in 5 Americans will develop it in their lifetime, and roughly 9,500 people are diagnosed every day. That volume is exactly why triage tools are useful, and exactly why anything suspicious deserves real eyes on it.
- Use AI to track changes and flag spots, not to rule cancer in or out
- Take clear, well-lit photos and keep a dated history of any changing spot
- Treat any "low concern" result as a prompt to keep watching, not a clearance
- Always confirm a concerning result with a licensed clinician
When to see a doctor
See a dermatologist or your primary-care clinician promptly, regardless of what an app says, if a spot is new, changing, or doesn't behave like your other moles. A helpful framework is the ABCDEs of melanoma: Asymmetry, Border irregularity, Color variation, Diameter larger than a pencil eraser, and Evolving over time.
Seek care sooner rather than later for a sore that won't heal, a spot that bleeds or itches persistently, or anything that simply worries you. No AI result should override that instinct. If you want a starting point, a clinician-overseen tool can help you organize your concern and route you to real care, but the diagnosis itself belongs with a licensed professional.
- A new or changing mole, especially one that stands out from the rest
- A sore that won't heal, bleeds, or scabs repeatedly
- Any spot matching the ABCDE warning signs
- A growth that itches, hurts, or worries you, even if an app says it's fine
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any new skincare treatment, especially if you have underlying health conditions, are pregnant, or are taking medications.
